Melanie Leveridge on ELRIG and a career in drug discovery
Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton abo...
Ausführliche Beschreibung
Autor*in: |
Melanie Leveridge [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2021 |
---|
Übergeordnetes Werk: |
In: Future Drug Discovery - Future Science Ltd, 2021, 3(2021), 1 |
---|---|
Übergeordnetes Werk: |
volume:3 ; year:2021 ; number:1 |
Links: |
---|
DOI / URN: |
10.4155/fdd-2020-0030 |
---|
Katalog-ID: |
DOAJ010637346 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ010637346 | ||
003 | DE-627 | ||
005 | 20230502072117.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4155/fdd-2020-0030 |2 doi | |
035 | |a (DE-627)DOAJ010637346 | ||
035 | |a (DE-599)DOAJ9835a389e95741e3beb1953ecb05312e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RS1-441 | |
100 | 0 | |a Melanie Leveridge |e verfasserin |4 aut | |
245 | 1 | 0 | |a Melanie Leveridge on ELRIG and a career in drug discovery |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. | ||
653 | 0 | |a Pharmacy and materia medica | |
773 | 0 | 8 | |i In |t Future Drug Discovery |d Future Science Ltd, 2021 |g 3(2021), 1 |w (DE-627)1760793973 |x 26313316 |7 nnns |
773 | 1 | 8 | |g volume:3 |g year:2021 |g number:1 |
856 | 4 | 0 | |u https://doi.org/10.4155/fdd-2020-0030 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/9835a389e95741e3beb1953ecb05312e |z kostenfrei |
856 | 4 | 0 | |u https://www.future-science.com/doi/10.4155/fdd-2020-0030 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2631-3316 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 3 |j 2021 |e 1 |
author_variant |
m l ml |
---|---|
matchkey_str |
article:26313316:2021----::eailvrdenliadcreid |
hierarchy_sort_str |
2021 |
callnumber-subject-code |
RS |
publishDate |
2021 |
allfields |
10.4155/fdd-2020-0030 doi (DE-627)DOAJ010637346 (DE-599)DOAJ9835a389e95741e3beb1953ecb05312e DE-627 ger DE-627 rakwb eng RS1-441 Melanie Leveridge verfasserin aut Melanie Leveridge on ELRIG and a career in drug discovery 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. Pharmacy and materia medica In Future Drug Discovery Future Science Ltd, 2021 3(2021), 1 (DE-627)1760793973 26313316 nnns volume:3 year:2021 number:1 https://doi.org/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/article/9835a389e95741e3beb1953ecb05312e kostenfrei https://www.future-science.com/doi/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/toc/2631-3316 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2021 1 |
spelling |
10.4155/fdd-2020-0030 doi (DE-627)DOAJ010637346 (DE-599)DOAJ9835a389e95741e3beb1953ecb05312e DE-627 ger DE-627 rakwb eng RS1-441 Melanie Leveridge verfasserin aut Melanie Leveridge on ELRIG and a career in drug discovery 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. Pharmacy and materia medica In Future Drug Discovery Future Science Ltd, 2021 3(2021), 1 (DE-627)1760793973 26313316 nnns volume:3 year:2021 number:1 https://doi.org/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/article/9835a389e95741e3beb1953ecb05312e kostenfrei https://www.future-science.com/doi/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/toc/2631-3316 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2021 1 |
allfields_unstemmed |
10.4155/fdd-2020-0030 doi (DE-627)DOAJ010637346 (DE-599)DOAJ9835a389e95741e3beb1953ecb05312e DE-627 ger DE-627 rakwb eng RS1-441 Melanie Leveridge verfasserin aut Melanie Leveridge on ELRIG and a career in drug discovery 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. Pharmacy and materia medica In Future Drug Discovery Future Science Ltd, 2021 3(2021), 1 (DE-627)1760793973 26313316 nnns volume:3 year:2021 number:1 https://doi.org/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/article/9835a389e95741e3beb1953ecb05312e kostenfrei https://www.future-science.com/doi/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/toc/2631-3316 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2021 1 |
allfieldsGer |
10.4155/fdd-2020-0030 doi (DE-627)DOAJ010637346 (DE-599)DOAJ9835a389e95741e3beb1953ecb05312e DE-627 ger DE-627 rakwb eng RS1-441 Melanie Leveridge verfasserin aut Melanie Leveridge on ELRIG and a career in drug discovery 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. Pharmacy and materia medica In Future Drug Discovery Future Science Ltd, 2021 3(2021), 1 (DE-627)1760793973 26313316 nnns volume:3 year:2021 number:1 https://doi.org/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/article/9835a389e95741e3beb1953ecb05312e kostenfrei https://www.future-science.com/doi/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/toc/2631-3316 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2021 1 |
allfieldsSound |
10.4155/fdd-2020-0030 doi (DE-627)DOAJ010637346 (DE-599)DOAJ9835a389e95741e3beb1953ecb05312e DE-627 ger DE-627 rakwb eng RS1-441 Melanie Leveridge verfasserin aut Melanie Leveridge on ELRIG and a career in drug discovery 2021 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. Pharmacy and materia medica In Future Drug Discovery Future Science Ltd, 2021 3(2021), 1 (DE-627)1760793973 26313316 nnns volume:3 year:2021 number:1 https://doi.org/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/article/9835a389e95741e3beb1953ecb05312e kostenfrei https://www.future-science.com/doi/10.4155/fdd-2020-0030 kostenfrei https://doaj.org/toc/2631-3316 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 3 2021 1 |
language |
English |
source |
In Future Drug Discovery 3(2021), 1 volume:3 year:2021 number:1 |
sourceStr |
In Future Drug Discovery 3(2021), 1 volume:3 year:2021 number:1 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Pharmacy and materia medica |
isfreeaccess_bool |
true |
container_title |
Future Drug Discovery |
authorswithroles_txt_mv |
Melanie Leveridge @@aut@@ |
publishDateDaySort_date |
2021-01-01T00:00:00Z |
hierarchy_top_id |
1760793973 |
id |
DOAJ010637346 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ010637346</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502072117.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4155/fdd-2020-0030</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ010637346</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9835a389e95741e3beb1953ecb05312e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS1-441</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Melanie Leveridge</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Melanie Leveridge on ELRIG and a career in drug discovery</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmacy and materia medica</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Future Drug Discovery</subfield><subfield code="d">Future Science Ltd, 2021</subfield><subfield code="g">3(2021), 1</subfield><subfield code="w">(DE-627)1760793973</subfield><subfield code="x">26313316</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4155/fdd-2020-0030</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9835a389e95741e3beb1953ecb05312e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.future-science.com/doi/10.4155/fdd-2020-0030</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2631-3316</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">2021</subfield><subfield code="e">1</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Melanie Leveridge |
spellingShingle |
Melanie Leveridge misc RS1-441 misc Pharmacy and materia medica Melanie Leveridge on ELRIG and a career in drug discovery |
authorStr |
Melanie Leveridge |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760793973 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RS1-441 |
illustrated |
Not Illustrated |
issn |
26313316 |
topic_title |
RS1-441 Melanie Leveridge on ELRIG and a career in drug discovery |
topic |
misc RS1-441 misc Pharmacy and materia medica |
topic_unstemmed |
misc RS1-441 misc Pharmacy and materia medica |
topic_browse |
misc RS1-441 misc Pharmacy and materia medica |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Future Drug Discovery |
hierarchy_parent_id |
1760793973 |
hierarchy_top_title |
Future Drug Discovery |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1760793973 |
title |
Melanie Leveridge on ELRIG and a career in drug discovery |
ctrlnum |
(DE-627)DOAJ010637346 (DE-599)DOAJ9835a389e95741e3beb1953ecb05312e |
title_full |
Melanie Leveridge on ELRIG and a career in drug discovery |
author_sort |
Melanie Leveridge |
journal |
Future Drug Discovery |
journalStr |
Future Drug Discovery |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2021 |
contenttype_str_mv |
txt |
author_browse |
Melanie Leveridge |
container_volume |
3 |
class |
RS1-441 |
format_se |
Elektronische Aufsätze |
author-letter |
Melanie Leveridge |
doi_str_mv |
10.4155/fdd-2020-0030 |
title_sort |
melanie leveridge on elrig and a career in drug discovery |
callnumber |
RS1-441 |
title_auth |
Melanie Leveridge on ELRIG and a career in drug discovery |
abstract |
Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. |
abstractGer |
Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. |
abstract_unstemmed |
Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
1 |
title_short |
Melanie Leveridge on ELRIG and a career in drug discovery |
url |
https://doi.org/10.4155/fdd-2020-0030 https://doaj.org/article/9835a389e95741e3beb1953ecb05312e https://www.future-science.com/doi/10.4155/fdd-2020-0030 https://doaj.org/toc/2631-3316 |
remote_bool |
true |
ppnlink |
1760793973 |
callnumber-subject |
RS - Pharmacy |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.4155/fdd-2020-0030 |
callnumber-a |
RS1-441 |
up_date |
2024-07-03T15:55:52.570Z |
_version_ |
1803573948657434624 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ010637346</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502072117.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.4155/fdd-2020-0030</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ010637346</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9835a389e95741e3beb1953ecb05312e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS1-441</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Melanie Leveridge</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Melanie Leveridge on ELRIG and a career in drug discovery</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Melanie Leveridge is a Senior Director at GSK, a science-led global healthcare company headquartered in Brentford, UK. She has recently been elected Chair of ELRIG (York, UK), the European Laboratory Research and Innovation Group. Here she speaks to Future Drug Discovery Editor Jennifer Straiton about what she hopes to achieve during her tenure as ELRIG Chair and gives her advice for Early Career Researchers just starting out in the field of drug discovery.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmacy and materia medica</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Future Drug Discovery</subfield><subfield code="d">Future Science Ltd, 2021</subfield><subfield code="g">3(2021), 1</subfield><subfield code="w">(DE-627)1760793973</subfield><subfield code="x">26313316</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:3</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.4155/fdd-2020-0030</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9835a389e95741e3beb1953ecb05312e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.future-science.com/doi/10.4155/fdd-2020-0030</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2631-3316</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">3</subfield><subfield code="j">2021</subfield><subfield code="e">1</subfield></datafield></record></collection>
|
score |
7.400199 |